Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment refers to specialty plasma therapies and normal source plasma (NSP). The Distribution segment focuses on the commercialization of in-licensed third-party biopharmaceutical products. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
462
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Kamada Ltd market cap is $470.68M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kamada Ltd 52 week high is $9.35 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kamada Ltd 52 week low is $6.60 as of November 18, 2026.
Kamada Ltd stock price today is $8.07.
Kamada Ltd stock price yesterday was $8.16.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Kamada Ltd's P/E ratio is 18.87.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Kamada Ltd P/B ratio is 1.7539.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Kamada Ltd 50-day moving average is $8.04.